LivaNova PLC, a market-leading medical technology company, announced the appointment of Donald (Don) Zurbay to the Company’s Board of Directors. Zurbay will serve on the Audit and Compliance Committee for the Board.
Health Technology Insights: Tolion to Launch AI Brain Coach App Beta on Sept 17, 2025
“LivaNova is pleased to welcome Don to our Board of Directors,” said William Kozy, Chair of the Board. “Over the course of 30 years, he has amassed expertise in finance, accounting, and strategy, much of which he honed while serving in leadership positions with global healthcare companies. His deep experience and knowledge will be welcome assets to the Board.”
Zurbay joins the LivaNova Board of Directors after a seven-year tenure at Patterson Companies, Inc., a global healthcare company. At Patterson, he served as President and Chief Executive Officer, after previously serving as Chief Financial Officer (CFO). Prior to Patterson, Zurbay spent nearly 13 years at St. Jude Medical, a global medical device company, in various leadership roles, culminating in his role as CFO. Other earlier career corporate experience includes tenures at PricewaterhouseCoopers, The Valspar Corporation, and Deloitte & Touche.
Health Technology Insights: Meroka Launches with $6 Million Seed Round to Restore Humanity in Healthcare
Currently, Zurbay sits on the Board of Directors at Sight Sciences, Inc., another publicly traded medical device company, where he chairs the Audit Committee and is a member of the Compensation Committee. His previous board appointments include Avedro, Inc. and Silk Road Medical, Inc. Zurbay holds a bachelor’s degree in business accounting from the University of Minnesota.
“I have spent the majority of my career immersed in the world of healthcare, serving patients and driving value for company shareholders,” Zurbay said. “I am honored to now join the LivaNova Board of Directors, supporting the Company to improve quality of life for patients around the world.”
With this appointment, the LivaNova Board is now comprised of 11 Directors.
Health Technology Insights: Atelerix and Rodon Global Partner on Cryo-Free Biotech Shipping
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- businesswire
